Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/6/2024
BioCity Presents Late-Breaking Phase 2 Results for IgA Nephropathy Tre...
11/6/2024
Pharma Firms Present Innovative Treatments for Major Diseases at CIIE
11/6/2024
MNCs and Chinese Partners Join Forces to Build an Innovative Healthcar...
11/5/2024
Aurobindo Challenges China in the Global Penicillin G Market with New ...
11/1/2024
Merck Faces Gardasil Sales Challenges in China, Impact Expected to Con...
10/31/2024
CirCode Advances Gene Therapy with HM2002 IND Approval
10/29/2024
Clover Announces Positive Results for RSV Vaccine SCB-1019 vs GSK's AR...
10/25/2024
China Expands Free HPV Vaccination to Reach 40% of Eligible Girls
10/24/2024
Sinopharm and Chinese Vaccine Makers Slash Prices Amid Fierce Market C...
10/24/2024
CASI Granted Chinese CTA Approval for CID-103 in Immune Thrombocytope...
10/21/2024
Changing Chinese Market Dynamics Hit Merck Where It Hurts (SCRIP Citel...
10/15/2024
Review of Online Drug Sales Growth in China 2021-2023
10/11/2024
CanSino Receives Over $17M from Gates Foundation to Accelerate Polio V...
10/11/2024
Chinese Health Insurance Premium Income Up 4.5% in 2023
10/2/2024
Publication Announcement on the Inclusion of Marstacimab as Pilot Proj...
10/1/2024
Akeso's Ebronucimab (PCSK9) Approved for Hypercholesterolemia in China
9/26/2024
CDE Issues the Technical Guidelines for Vaccine Immunogenicity Bridgin...
9/13/2024
Fosun Pharma to Acquire Full Ownership of Fosun Kite and Strengthens P...
9/12/2024
Innovent's Mazdutide Outperforms Trulicity in Phase III Type 2 Diabete...
9/11/2024
China to Implement Comprehensive Measures to Enhance Insurance Sector ...
9/9/2024
Akeso, Summit's PD-1 Bispecific Beats Merck's Keytruda in China-Only S...
9/3/2024
CDE Solicits Comments on Draft of the Technical Guidelines for Vaccine...
8/30/2024
Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor...
8/29/2024
CDE Solicits Comments on Draft of the Technical Guidelines for Non-Cli...
8/28/2024
CDE Solicits Comments on the Technical Guidelines for Non-Clinical Eff...
8/28/2024
CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
8/27/2024
Legend Biotech Wins Chinese Approval of CAR-T Carvykti (Cilta-cel)
8/27/2024
Sanofi Suspends Supply and Sale of Flu Vaccine in China
8/26/2024
CDE Solicits Public Comments on the Technical Guidelines for Pharmaceu...
8/26/2024
Chinese Pharma Cos Set Sights on Dominating Therapeutic Cancer Vaccine...
Page:
3
/
71
Total number of articles:
2126
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit